HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells

被引：11
|
作者：
Meyer, Paul N. [1 ]
Roychowdhury, Shantanu [1 ]
Kini, Ameet R. [1 ]
Alkan, Serhan [1 ]
机构：
[1] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
来源：
LEUKEMIA RESEARCH | 2008年 / 32卷 / 01期
关键词：
acute promyelocytic leukemia; APL; 17AAG; heat shock protein; HSP90; apoptosis; therapy; geldanamycin;
D O I：
10.1016/j.leukres.2007.05.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The effects of a novel heat shock protein inhibitor, 17AAG, on established APL cell lines (NB4 and R1) were analyzed. 17AAG induces apoptosis in APL cell lines both sensitive (NB4) and resistant (R 1) to ATRA after 72 h of incubation. Apoptosis occurs by a mechanism different than ATRA-inediated response, as the cells do not undergo differentiation before apoptosis. Analysis of bax and bcl-2 shows that pro-apoptotic (bax) and anti-apoptotic (bcl-2) proteins are decreased in expression after incubation with 17AAG. We believe this data supports potential clinical use of agents that target HSP90 in APL patients failing conventional therapy. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：143 / 149
页数：7
相关论文
共 50 条
  • [1] Stability of the Hsp90 Inhibitor 17AAG Hydroquinone and Prevention of Metal-Catalyzed Oxidation
    Guo, Wenchang
    Siegel, David
    Ross, David
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (12) : 5147 - 5157
  • [2] Low dose Hsp90 inhibitor 17AAG protects neural progenitor cells from ischemia induced death
    Eric Bradley
    Xiaying Zhao
    Rebecca Wang
    Darrell Brann
    Erhard Bieberich
    Guanghu Wang
    Journal of Cell Communication and Signaling, 2014, 8 : 353 - 362
  • [3] Hsp90 inhibition with 17AAG can sensitize human breast cancer cells to taxol
    Kudryavtsev, V.
    Makarova, Y.
    Kabakov, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 86 - 86
  • [4] Low dose Hsp90 inhibitor 17AAG protects neural progenitor cells from ischemia induced death
    Bradley, Eric
    Zhao, Xiaying
    Wang, Rebecca
    Brann, Darrell
    Bieberich, Erhard
    Wang, Guanghu
    JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2014, 8 (04) : 353 - 362
  • [5] Intratumor injection of the hsp90 inhibitor 17AAG decreases tumor growth and induces apoptosis in a prostate cancer xenograft model
    Williams, Christopher R.
    Tabios, Ray
    Linehan, W. Marston
    Neckers, Len
    JOURNAL OF UROLOGY, 2007, 178 (04): : 1528 - 1532
  • [6] Combination of the mTOR inhibitor Rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG) inhibits proliferation and induces apoptosis in multiple myeloma (MM).
    Kasdan, LA
    Lu, G
    Singha, U
    Lentzsch, S
    Roodman, GD
    Ghobrial, IM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 863S - 863S
  • [7] Modulation of HSP90 co-chaperone AHA1 increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG).
    Holmes, J
    Sharp, SY
    Workman, P
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9157S - 9157S
  • [8] Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer
    Zajac, Magdalena
    Gomez, Gonzalo
    Benitez, Javier
    Martinez-Delgado, Beatriz
    BMC MEDICAL GENOMICS, 2010, 3
  • [9] Primaquine phosphate induces the apoptosis of ATRA-resistant acute promyelocytic leukemia cells by inhibition of the NF-κB pathway
    Ma, Lan
    Chen, Lianjuan
    Li, Haoying
    Ge, Lu
    Wang, Siheng
    Zhang, Zhida
    Huang, He
    Shi, Liuzhi
    Li, Tong
    Gu, Haihua
    Lyu, Jianxin
    He, Licai
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 107 (04) : 685 - 693
  • [10] The Hsp90 inhibitor 17-AAG sensitizes human leukemia cells to proteasome inhibitor PS-341.
    Yao, Q
    Kersey, JH
    BLOOD, 2003, 102 (11) : 622A - 623A
12345